Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants
21 sept. 2022 12h54 HE
|
Lactiga, Inc
NORTH BRUNSWICK, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary...